Virology: new insights into detection of viral pathogens

Virology needs tools to track mutating viruses and manage outbreaks.

Virology: <span>new insights</span> into detection of <span>viral pathogens</span>

Overview

Virology requires advanced, adaptable tools to track rapidly mutating viruses and manage emerging outbreaks.

Virology faces unique challenges, such as tracking mutating viruses and managing outbreaks. These require fast, reliable, and adaptable tools.

Some viruses instead viruses, SARS-CoV-2 and HIV are hard to monitor due to their genetic variability and rapid mutation, requiring advanced diagnostics.

Nucleotica
01

Virus genome detection.

High sensitivity for viral pathogens pathogens.

Specialized sensors accurately detect virus genomes, even in low concentrations, ensuring early identification of viral infections.

Wide application range.

Ideal for studying a wide range of DNA and RNA viruses such as SARS-CoV-2, influenza, dengue, and Zika.

Low sample requirement.

Requires only minimal sample volumes, making it easier to work with low quality or insufficient samples.
02

Adaptable technology for highly variable pathogens.

Handles rapid mutations.

Nucleotica nanosensors could be adapted extremely fast to any newly discovered mutations in viral genomes, making it invaluable for detecting quickly evolving viruses.

Custom panels.

Allows the creation of detection panels for specific virus strains or mutations, providing tailored solutions for ongoing and emerging research needs.

Vaccine & therapy development.

Supports the development of vaccines and antiviral therapies by identifying critical mutations that impact disease progression and treatment efficacy.

Tracking evolution.

The platform can identify newly discovered changes in viral genetic sequences over time, helping researchers study viral adaptation, resistance, and transmission dynamics.
03

Portability and field-readiness.

Compact design.

The platform’s lightweight, portable design ensures that diagnostics can be conducted in diverse environments, from high-tech labs to remote outbreak sites.

Rapid results.

Delivers real-time results in under 30 minutes, empowering virologists to act quickly during outbreaks or field studies.

Impact on Virology research and Public health

Solutions of Nucleotica supports outbreak response and research with rapid diagnostics and genomic insights.

Preparedness and response.

Detects emerging viral threats early, providing the critical data needed to implement timely containment measures.

Enhances pandemic preparedness by identifying and tracking newly discovered viral strains.

Epidemiological insights.

Helps health organizations understand viral transmission patterns, aiding effective control strategies.

Offers detailed genomic analysis to identify sources of outbreaks and track their progression.

Advancing vaccine development.

Supports preclinical and clinical research by identifying key mutations that may impact vaccine efficacy or drug resistance.

Enables researchers to test and validate antiviral compounds against specific viral genotypes.

Empowering global health.

Provides portable and cost-effective diagnostics for low-resource regions, where centralized labs are often inaccessible.

Facilitates global collaboration by enabling standardized testing and protocols.

Applications

Our solution improves virology, outbreak response, and global health with rapid diagnostics and vaccine support.

01
Clinical virology.

Clinical virology.

Routine diagnostics for RNA viruses, including influenza, RSV, and coronaviruses.

Monitoring antiviral resistance and mutation rates in chronic infections such as HIV and hepatitis C.

02
Outbreak response.

Outbreak response.

Rapid deployment in field settings for early detection and containment of emerging viral threats.

Real-time mutation tracking to guide public health decisions and response strategies.

03
Academic and pharmaceutical research.

Academic and pharmaceutical research.

Genomic studies on viral evolution, host-pathogen interactions, and disease mechanisms.

Supporting the development of next-generation vaccines and antiviral therapies.

04
Global health and epidemiology.

Global health and epidemiology.

Field-ready diagnostics for underserved regions, enabling widespread monitoring and control of viral diseases.

Contributing to global surveillance networks by providing accurate and timely data on viral genetic changes.

Nucleotica

Why choose the Nucleotica Platform for Virology?

Fast detection.

Provides rapid and reliable insights into viral genomes, ensuring timely interventions and research outcomes.

Adaptability.

Handles highly variable and mutating pathogens, making it a versatile tool for diverse virology needs.

Portability.

Compact and easy to use in any setting, from high-tech labs to remote field sites.

Cost-effective.

Reduces the need for expensive lab infrastructure while maintaining high diagnostic accuracy.

Future-proof tech.

Customizable panels and upgradable software keep the platform relevant to new viral threats.

Contact us

Reach out to start your next innovation today.